Preparation technology of ropivacaine mesoporous bioactive glass composite microspheres

A technology of bioactive glass and composite microspheres, which can be used in drug combinations, organic active ingredients, microcapsules, etc., and can solve problems such as lack of research

Active Publication Date: 2021-08-31
无锡市锡山人民医院
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] But so far there is no relevant research on the ropivacaine sustained-release drug delivery system using MBG as the carrier.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation technology of ropivacaine mesoporous bioactive glass composite microspheres
  • Preparation technology of ropivacaine mesoporous bioactive glass composite microspheres
  • Preparation technology of ropivacaine mesoporous bioactive glass composite microspheres

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Example 1: The specific preparation method of the ropivacaine mesoporous bioactive glass composite microspheres provided in this example is as follows:

[0033] Step 1: SiO 2 Preparation of colloidal crystal templates

[0034] Monodisperse SiO 2 Preparation of Microspheres: Using A method for the preparation of monodisperse SiO by an alkaline hydrolysis process of ethyl orthosilicate (TEOS) 2 microsphere suspension. Weigh 251.2g absolute ethanol, 118.25g deionized water and 34g NH 3 ·H 2 O was placed in an Erlenmeyer flask, and after mixing evenly under magnetic stirring, 27.7g TEOS was added, and magnetic stirring was continued for 3h to obtain SiO 2 Suspension of particles.

[0035] SiO 2 Preparation of colloidal crystal template: firstly, the SiO prepared above 2 The suspension of particles was rotovaped to remove excess solvent, which was then placed in a flat-bottomed vessel and centrifuged to remove excess solvent, resulting in large, disordered SiO 2 c...

Embodiment 2

[0044] Example 2: The preparation method is the same as in Example 1, except that in step 5, the PEG with a molecular weight of 6,000 is replaced with PEG with a molecular weight of 10,000, and the pressurized plane is made of glass. The pressurized pressure was 0.054 MPa.

Embodiment 3

[0045] Example 3: The preparation method is the same as that of Example 1, except that in step 5, the PEG with a molecular weight of 6,000 is replaced with PEG with a molecular weight of 20,000, and ceramics are used for the pressing plane. The pressurized pressure is 0.08 MPa.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Mohs hardnessaaaaaaaaaa
Login to view more

Abstract

The invention relates to a preparation process of ropivacaine mesoporous bioactive glass composite microspheres, comprising the following steps: Step 1: SiO 2 Preparation of colloidal crystal template; Step 2: Preparation of reverse colloidal crystal carbon template; Step 3: Preparation of MBGs; Step 4: Loading of drugs in MBGs; Step 5: Preparation of composite microspheres; MBGs and drug-loaded-MBGs powder are evenly dispersed, spread on a flat surface with sufficient surface strength, and then press another flat, smooth surface with sufficient hardness on MBGs and drug-loaded-MBGs powder to pressurize and adjust Pressurize, then add the chloroform solution of PEG and PLA-PEG drop by drop around the MBGs and drug-loaded-MBGs powder, just moisten, and keep ventilated at room temperature until the chloroform is volatilized.

Description

technical field [0001] The invention relates to the technical field of preparation of sustained-release medicines, in particular to a preparation process of ropivacaine mesoporous bioactive glass composite microspheres Background technique [0002] Pain is an unpleasant sensory and emotional experience resulting from tissue damage or potential tissue damage. Acute pain is often related to surgical trauma, tissue damage, or certain disease states, and the duration is usually less than one month, which belongs to nociceptive pain. Postoperative pain refers to the acute pain that occurs immediately after surgery, and usually lasts no more than 7 days. In traumatic thoracic surgery and joint replacement that requires long-term functional exercise, sometimes analgesia needs to last for several weeks. Postoperative pain in limbs has a severe negative impact on the quality of postoperative recovery and functional exercise of patients. For persistent pain after surgery, there are ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/50A61K31/445A61K47/34A61K9/16A61K47/02A61P23/00A61P29/00
CPCA61K9/1611A61K9/5031A61K9/5089A61K31/445A61K47/02A61P23/00A61P29/00
Inventor 刘清仁范健纪立军
Owner 无锡市锡山人民医院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap